DBV Technologies SA (DBVT)
16.75
+2.85
(+20.50%)
USD |
NASDAQ |
Dec 08, 13:30
DBV Technologies EPS Diluted (Quarterly): -1.207 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| EDAP TMS SA | -0.1565 |
| Cellectis SA | 0.0058 |
| Genfit SA | -- |
| Ascendis Pharma A/S | -1.173 |
| Akari Therapeutics Plc | -0.1948 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.02M |
| Total Expenses (Quarterly) | 33.02M |
| Enterprise Value | 326.49M |
| Earnings Yield | -31.29% |
| Normalized Earnings Yield | -31.29 |